December 4th-5th, 2019
Royal Continental Hotel, Naples, Italy

Invited Faculty

Paolo A. Ascierto
Director, Medical Oncology, Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, National Cancer Institute Fondazione "G. Pascale", Naples, Italy

Carlo Bifulco
Medical Director of Oncological Molecular Pathology and Pathology Informatics, Providence Oregon Regional Laboratory and Earle A. Chiles Research Institute, Portland, Oregon, US

Alfredo Budillon
Director Experimental Pharmacology Unit, Department of Research, National Cancer Institute "Fondazione G. Pascale", Naples, Italy

Lisa H. Butterfield
Research Center Vice President, Parker Institute for Cancer Immunotherapy and Adjunct Professor of Microbiology and Immunology, University of California, San Francisco, California, US

Katie Campbell
Department of Medicine, University of California, Los Angeles, California, US

Bruno Daniele
Director of Clinical Oncology Unit, Hospital "del Mare", ASL Napoli 1 Centro, Naples, Italy

Michael Dougan
Assistant Professor of Medicine, Massachusetts General Hospital, Boston, Massachusetts, US

Leisha Emens
Director of Translational Immunotherapy for the Women's Cancer Research Center , UPMC Hillman Cancer Center/Magee Women's Hospital, Co-Leader, Hillman Cancer Immunology/Immunotherapy Program, Pittsburgh, Pennsylvania, US

Silvia Formenti
Sandra and Edward Meyer Professor of Cancer Research, Chairman, Department of Radiation Oncology, Weill Cornell Medicine, New York, New York, US

Jerome Galon
Research Director, National Institute of Health and Medical Research (INSERM), Paris, France

Claus Garbe
Professor of Dermatology, Center for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany

John B. Haanen
Consultant Medical Oncologist, CSO Immunotherapy and Staff Scientist in the Division of Immunology, Professor of Translational Immunotherapy of Cancer, Leiden University Medical Centre, Amsterdam, The Netherlands

Filip Janku
Associate Professor of Medicine, Center Medical Director, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, US

Samir N. Khleif
Director of the Loop Immuno-Oncology Laboratory, Biomedical Scholar and Professor of Oncology, Georgetown University Medical School, Washington, DC, US

Tomas Kirchhoff
Associate Professor, Department of Population Health Associate Professor, Department of Environmental Medicine, Perlmutter Cancer Center, New York City, New York, US

Jennifer Mcquade
Assistant Professor, Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, US

Alessandro Morabito
Director of Medical Oncology, Lung Department, National Cancer Institute Fondazione "G. Pascale", Naples, Italy

Yana Najjar
Assistant Professor of Medicine, Division of Hematology-Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, US

Paul Nathan
Consultant Medical Oncologist, Mount Vernon Cancer Centre, Northwood, Middlesex, UK

Volkmar Nuessler
Director of Tumor Center, Munich, Germany

kunle Odunsi
Cancer Center Deputy Director, The M. Steven Piver Professor and Chair, Department of Gynaecologic Oncology, Executive Director, Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, New York, US

Hideho Okada
Professor and Director Brain Tumor Immunotherapy Center in Neurological Surgery, University of California San Francisco, Parker Institute for Cancer Immunotherapy, San Francisco, California, US

Akash Patnaik
Assistant Professor of Medicine, Hematology and Oncology, Director of Laboratory for Developmental Therapeutics Attending Physician, Genitourinary Oncology Program, The University of Chicago Comprehensive Cancer Center Knapp Center for Biomedical Discovery, Chicago, Illinois, US

Crystal Paulos
Associate Professor and Endowed Peng Chair, Department of Microbiology and Immunology Hollings Cancer Center, Medical University of South Carolina (MUSC), Charleston, South Carolina, US

Sandro Pignata
Head of the Uro-Gynaecological Department, National Cancer Institute “Fondazione G. Pascale”, Naples, Italy

Igor Puzanov
Director, Early Phase Clinical Trials Program, Chief of Melanoma, Co-Leader, CCSG Experimental Therapeutics Program, Professor of Oncology, Department of Medicine, Roswell Park Comprehensive Cancer Center, Developmental Therapeutics, Buffalo, New York, USA

Sergio Quezada
Professor of Cancer Immunology and Immunotherapy, Group Leader of Cancer Immunology Unit, Research Department of Hematology, Cancer Institute, University College London, London, UK

Bradley I. Reinfeld
Vanderbilt School of Medicine, Nashville, Tennessee, US

Heath Skinner
Associate Professor of Radiation Oncology, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, US

Hussein Tawbi
Associate Professor, Director of Melanoma Clinical Research & Early Drug Development, Melanoma Medical Oncology, Investigational Cancer Therapeutics, UT MD Anderson Cancer Center, Houston, Texas, US

John Timmerman
Professor of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine , UCLA Medical Center, Los Angeles, California, US

Giorgio Trincheri
NIH Distinguished Investigator, Director, Cancer and Inflammation Program (CIP), Center for Cancer Research, NCI, NIH, Bethesda, Maryland, US

For information please contact info@melanomabridge.org